Invention Grant
- Patent Title: Nrf2 regulators
-
Application No.: US15105306Application Date: 2014-12-17
-
Publication No.: US10144731B2Publication Date: 2018-12-04
- Inventor: Thomas Glanmor Davies , Alison Jo-anne Woolford , Hendrika Maria Gerarda Willems , David Norton , Thomas Daniel Heightman , Jeffrey K. Kerns
- Applicant: GlaxoSmithKline Intellectual Property Development Limited , Astex Therapeutics, Ltd
- Applicant Address: GB Brentford, Middlesex GB Cambridge
- Assignee: GlaxoSmithKline Intellectual Property Development Limited,Astex Therapeutics, Ltd
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited,Astex Therapeutics, Ltd
- Current Assignee Address: GB Brentford, Middlesex GB Cambridge
- Agent Nora L. Stein; Edward R. Gimmi
- International Application: PCT/IB2014/067027 WO 20141217
- International Announcement: WO2015/092713 WO 20150625
- Main IPC: C07D249/18
- IPC: C07D249/18 ; C07D417/10 ; C07D281/02 ; C07D291/08 ; C07D401/12 ; C07D403/12 ; C07D405/12 ; C07D417/14 ; C07D419/10 ; C07D419/14 ; C07D471/04 ; C07D513/04 ; C07D515/04
Abstract:
The present invention relates to bis aryl analogs, pharmaceutical compositions containing them and their use as Nrf2 regulators.
Public/Granted literature
- US20160318917A1 NRF2 REGULATORS Public/Granted day:2016-11-03
Information query
